ICU vs FEMY

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 24, 2026

ICU

45.2
AI Score
VS
ICU Wins

FEMY

39.8
AI Score

Investment Advisor Scores

ICU

45score
Recommendation
HOLD

FEMY

40score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric ICU FEMY Winner
Forward P/E 0 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth 82.0% -18.9% ICU
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 45.2/100 39.8/100 ICU
Profit Margin 0.0% 0.0% Tie
Beta 1.00 1.00 Tie
AI Recommendation HOLD AVOID NEW MONEY ICU

Relative Price Performance (Last 90 Days)

ICU 1M: -29.9% · 3M: -32.5% FEMY 1M: -38.3% · 3M: -51.0%

Current Technical Phase

ICU

Markdown
Sell / avoid

Price below a falling SMA50 (slope -0.8%), weak momentum, RSI 37

RSI (14): 36.8 · Price: $2.41

FEMY

Markdown
Sell / avoid

Price below a falling SMA50 (slope -15.8%), weak momentum, RSI 29

RSI (14): 28.7 · Price: $1.50

Fundamentals Snapshot

Metric ICU FEMY
Market Cap — —
Forward P/E -1.0 -0.7
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.8% -0.2%
Gross Margin 0.9% 0.6%
Operating Margin -6.2% -15.3%
EPS -2.97 -3.28
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, ICU is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.